Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Low-Fat Meal May Boost Costly Cancer Drug

Posted 1 day 22 hours ago by Drugs.com

FRIDAY, Feb. 17, 2017 – Eating a low-fat meal when taking an expensive prostate cancer drug can cut the cost of the drug by three-quarters, a new study indicates. "We know this drug [Zytiga] is absorbed much more efficiently when taken with food," said study author Dr. Russell Szmulewitz, an assistant professor of medicine at the University of Chicago. "It's inefficient, even wasteful, to take this medicine while fasting, which is how the drug's label says to take it," he noted in a university news release. But, Szmulewitz cautioned that patients shouldn't start experimenting with drug doses on their own. "This was a relatively small study, too small to show with confidence that the lower dose is as effective. It gives us preliminary, but far from definitive, evidence. Physicians should use their discretion, based on patient needs," he advised. Zytiga (abiraterone acetate) costs more ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Zytiga, Prostate Tumor - Benign

Cancer Survivors Gain From Web-Based Health Care

Posted 9 days ago by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Cervical Cancer, Bladder Cancer, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Testicular Cancer, Zollinger-Ellison Syndrome, Wilms' Tumor, Solid Tumors

Hormonal Drug Boosts Survival After Prostate Cancer's Return: Study

Posted 18 days ago by Drugs.com

WEDNESDAY, Feb. 1, 2017 – When prostate cancer recurs after surgery, treatment with both radiation and a testosterone-suppressing drug can extend some men's lives, a new clinical trial finds. In a nearly 20-year study, researchers found that the combination therapy cut the risk of death from prostate cancer in half, compared to radiation alone. And that translated into better overall survival, the researchers reported in the Feb. 2 New England Journal of Medicine. After 12 years, just over 76 percent of men who'd received radiation and the hormonal drug bicalutamide (Casodex) were still alive. That compared with just over 71 percent of those who'd received radiation alone. Not all patients benefited from extra treatment, though – including those with "lower-risk" prostate cancer that, despite recurring, appeared less aggressive. And the testosterone-blocking drug carried expected side ... Read more

Related support groups: Prostate Cancer, Transurethral Prostatectomy, Casodex, Bicalutamide, History - Radiation Therapy, Genitourinary Surgical and Other Conditions

What You Don't Know About Cancer Can Kill You

Posted 18 days ago by Drugs.com

WEDNESDAY, Feb. 1, 2017 – Cancer isn't inevitable, but many Americans don't know that several lifestyle factors affect their risk of developing the disease, a new survey finds. Only one in two Americans is aware that obesity can raise the risk of cancer. And fewer than half understand that alcohol, inactivity, processed meat, eating lots of red meat and low consumption of fruits and vegetables are linked to cancer risk, the researchers said. "There is a clear crisis in cancer prevention awareness," said Alice Bender, head of nutrition programs at the American Institute for Cancer Research. A larger percentage of Americans mistakenly believe that stress, fatty diets and other unproven factors are linked with cancer, according to the institute's 2017 Cancer Risk Awareness Survey. "It's troubling that people don't recognize alcohol and processed meats increase cancer risk," Bender said in ... Read more

Related support groups: Obesity, Cancer, Smoking, Breast Cancer, Prostate Cancer, Smoking Cessation, Alcohol Dependence, Nicotine, Colorectal Cancer, Sunburn, Skin Cancer, Alcoholism, Nicorette, Hangover, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Prevention of Sunburn, Acute Alcohol Intoxication

Anxiety May Lead to Unneeded Prostate Cancer Treatments

Posted 27 Jan 2017 by Drugs.com

FRIDAY, Jan. 27, 2017 – Anxiety may prompt prostate cancer patients to opt for potentially unnecessary treatments, a new study suggests. The research included more than 1,500 men newly diagnosed with localized prostate cancer. They were more likely to choose surgery and radiation therapy than active surveillance. Active surveillance – also known as "watchful waiting" – is when the patient is monitored closely, but not treated. "Men's level of emotional distress shortly after diagnosis predicted greater likelihood of choosing surgery over active surveillance," said the researchers from the University at Buffalo and Roswell Park Cancer Institute in Buffalo, N.Y. "Importantly, this was true among men with low-risk disease, for whom active surveillance may be a clinically viable option and side effects of surgery might be avoided," they noted. Though the study found an association ... Read more

Related support groups: Anxiety, Anxiety and Stress, Erectile Dysfunction, Prostate Cancer, Urinary Incontinence, Genitourinary Surgical and Other Conditions

Mental Health May Affect Chances Against Cancer

Posted 26 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Anxiety and depression may increase the risk of death from certain cancers, early research suggests. After analyzing studies involving thousands of patients in Great Britain, researchers found that people with greater levels of psychological distress had higher death rates for colon, esophageal, pancreatic and prostate cancers and leukemia. The study was published Jan. 25 in the BMJ. "Our findings contribute to the evidence that poor mental health might have some predictive capacity for certain physical diseases, but we are a long way off from knowing if these relationships are truly causal," said researcher David Batty in a journal news release. Batty is with University College London. He and his colleagues reviewed 16 English and Scottish studies that included more than 163,000 people, aged 16 and older. The people were initially cancer-free and followed ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Major Depressive Disorder, Prostate Cancer, Colorectal Cancer, Dysthymia, Psychiatric Disorders, Pancreatic Cancer, Head and Neck Cancer

U.S. Cancer Deaths Decline Over Three Decades

Posted 24 Jan 2017 by Drugs.com

TUESDAY, Jan. 24, 2017 – While cancer death rates have dropped 20 percent overall in the United States since 1980, high death rates persist in pockets throughout the country, a new report finds. "Death rates differ dramatically between different types of cancers, and certain regions saw great progress in reducing cancer deaths and others fell behind," said lead researcher Dr. Christopher Murray. In all, 160 counties showed increases in cancer death rates between 1980 and 2014, noted Murray, director of the Institute for Health Metrics and Evaluation at the University of Washington in Seattle. For example, lung cancer kills more people in the United States than any other cancer, but death rates are more than 20 times higher in some parts of the country than others, he said. "Fewer Americans smoke today than in previous decades, but parts of the South and many rural areas still show high ... Read more

Related support groups: Cancer, Smoking, Breast Cancer, Prostate Cancer, Smoking Cessation, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Nicotrol TD, Nicorelief, Nicorette DS, Nicotrol NS, ProStep

U.S. Cancer Death Rates Continue to Fall: Report

Posted 5 Jan 2017 by Drugs.com

THURSDAY, Jan. 5, 2017 – Cancer death rates in the United States have dropped 25 percent since the early 1990s, a new report reveals. The finding was drawn from the American Cancer Society's latest cancer incidence and mortality estimates, which indicate that in 2017, close to 1.7 million Americans will be diagnosed with cancer and about 600,000 U.S. cancer patients will die. "The drop in cancer mortality is primarily the result of large declines in the four major causes of cancer death – lung, colorectal, breast and prostate – which account for almost half of all cancer deaths," noted report author Rebecca Siegel. She is strategic director for surveillance and health services research at the cancer society. "This progress is driven by declines in smoking prevalence beginning in the 1960s, and improvements in the early detection of cancer and cancer treatment," Siegel explained. The ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer

Powerful Drug for Advanced Cancers May Need Less Frequent Dosing

Posted 4 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 4, 2017 – Use of a bone cancer drug once every three months, instead of monthly, does not boost the risk of bone problems over two years, a new study finds. That could reduce side effects from the drug, known as zoledronic acid (Zometa), and increase cost savings, the researchers said. The drug is used to treat the spread of breast cancer, prostate cancer and multiple myeloma to the bone. Current guidelines suggest that zoledronic acid be given intravenously every three to four weeks to reduce cancer-linked pain, as well as the risk of bone problems, such as broken bones. However, the drug comes with its own, often serious, side effects. "It can cause flu-like symptoms and bone pain in the short term," noted one oncologist, Dr. Jane Carleton. She's associate chief of clinical affairs at Northwell Health Cancer Institute in Lake Success, N.Y. According to Carleton, ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Breast Cancer, Metastatic, Reclast, Multiple Myeloma, Zometa, Aclasta, Zoledronic Acid, Osteolytic Bone Lesions of Multiple Myeloma

New Prostate Cancer Therapy Works Without Severe Side Effects

Posted 21 Dec 2016 by Drugs.com

A new treatment for early stage Prostate Cancer is "transformative," according to researchers. The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment. Only six percent of those who had the treatment had to undergo prostate removal, compared with 30 percent who did not have the new therapy. Many prostate cancer patients who have surgery or radiation therapy have lifelong impotence and urinary incontinence. But sexual and urination problems lasted no longer than three months among patients who had the new therapy, according to the study in The Lancet Oncology. The drug used in the treatment is made from bacteria that live in near total darkness on the ... Read more

Related support groups: Cancer, Erectile Dysfunction, Prostate Cancer, Urinary Incontinence

Health Highlights: Dec. 20, 2016

Posted 20 Dec 2016 by Drugs.com

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: New Prostate Cancer Therapy Works Without Severe Side Effects A new treatment for early stage prostate cancer is "transformative," according to researchers. The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment. Only six percent of those who had the treatment had to undergo prostate removal, compared with 30 percent who did not have the new therapy. Many prostate cancer patients who have surgery or radiation therapy have lifelong impotence and urinary incontinence. But sexual and urination problems lasted no longer than three months among patients who ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Urinary Incontinence

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 4 Dec 2016 by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

Cancer Advances Demand Continual Funding, Specialists Say

Posted 29 Nov 2016 by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Bladder Cancer, Head and Neck Cancer

Cancer Can Devour Income of Medicare-Only Patients

Posted 23 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 23, 2016 – Medical bills for older U.S. cancer patients can eat up one-quarter of their income or more if they have Medicare without supplemental insurance, a new study says. Hospitalization is a major reason why seniors with the government-funded insurance program have high out-of-pocket costs for cancer care, the researchers concluded. "The spending associated with a new cancer diagnosis gets very high quickly, even if you have insurance," said study co-author Lauren Hersch Nicholas, an assistant professor at the Bloomberg School of Public Health at Johns Hopkins University in Baltimore. "The physical disease is terrible and then you have to figure out how to deal with the economic fallout associated with paying to treat it," she said in a university news release. Nicholas and her colleagues examined data from more than 1,400 Medicare patients diagnosed with cancer ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer

Palliative Care Raises Quality of Life, But Doesn't Extend It

Posted 22 Nov 2016 by Drugs.com

TUESDAY, Nov. 22, 2016 – Palliative care can ease the burden that a serious illness places on both a patient and loved ones, but there's no evidence that it can extend the life of a sick person, a review of the available evidence has concluded. People who receive palliative care have better quality of life and fewer symptoms than people who don't receive such care, said study lead author Dio Kavalieratos. He is an assistant professor at the University of Pittsburgh School of Medicine's Section of Palliative Care and Medical Ethics. But there's no evidence that palliative care has any impact on how long a patient will live, Kavalieratos added. "We didn't find an association at all," he said. "There was no relationship between receiving palliative care and time until death." Palliative care focuses on providing seriously ill patients relief from their symptoms, pain and stress, ... Read more

Related support groups: Pain, Anxiety and Stress, Cancer, Breast Cancer, Prostate Cancer, Breast Cancer - Palliative

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Lupron, Premarin, ethinyl estradiol, Estrace, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, view more... Casodex, Eligard, Taxotere, Cenestin, Enjuvia, cyclophosphamide, Xtandi, bicalutamide, capecitabine, degarelix, flax, leuprolide, Menest, esterified estrogens, Trelstar, docetaxel, Provenge, Firmagon, abiraterone, Progynova, Trelstar LA, Xofigo, Vantas, conjugated estrogens, goserelin, Flax Seed Oil, Supprelin LA, Trelstar Depot, radium 223 dichloride, flutamide, Thais, Sandrena, Premarin Intravenous, sipuleucel-t, triptorelin, cabazitaxel, Lupron Depot 11.25 mg, Jevtana, Zoladex 3-Month, Delestrogen, Viadur, Cytadren, diethylstilbestrol, Stilphostrol, Thaissept, estramustine, histrelin, nilutamide, Estratab, Docefrez, mitoxantrone, Primogyn Depot, Plenaxis, Estinyl, aminoglutethimide, Emcyt, Novantrone, Nilandron, Eulexin, Valergen, Oromone, Provames, abarelix, Zumenon, enzalutamide, Progynova TS, Systen